The FDA has cleared the trial so obviously they were happy with the detail, especially on safety and efficacy. The company has a very clear idea of the mechanisms of actions or else they wouldn’t be going to the clinic with D2 diabetes which they are fully funding … AT THIS STAGE (But dont ink that in ). Maybe expect more information when the half-year results are announced before the end of the month. And thanks again for your input Q. Cheers Vin
diabetes data - more info required, page-7
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.03 |
Change
0.080(8.42%) |
Mkt cap ! $1.176B | |||
| Open | High | Low | Value | Volume |
| 95.5¢ | $1.03 | 95.0¢ | $43.38M | 42.28M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 72752 | $1.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.03 | 205100 | 2 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |